RSLS - ReShape Lifesciences - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ReShape Lifesciences's activity chart (see below) currently has 8 price targets and 8 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 68.67 days.

Most recent stock forecast was given by ANTHONY VENDETTI from MAXIM GROUP on 17-Jul-2024. First documented stock forecast 31-Oct-2016.

Best performing analysts who are covering RSLS - ReShape Lifesciences:

Kyle Rose Ben Haynor Rick Wise Anthony Vendetti David Solomon

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Oct-2021

$434999.47

2 years 3 months 4 days ago
(17-Jul-2024)

0/3 (0%)

$318043.31 (271.93%)

$507499.38

$507483.72 (3236503.25%)

4 years 2 months 4 days ago
(17-Aug-2022)

0/2 (0%)

$380683.28 (300.19%)

Hold Since 22-May-2019

$326250

$326234.31 (2080576.00%)

$326250

7 years 4 months 29 days ago
(22-May-2019)

2/2 (100%)

$-673750 (-67.38%)

86

Hold Since 26-Feb-2019

$598125

$598109.31 (3814472.75%)

7 years 7 months 25 days ago
(26-Feb-2019)

1/1 (100%)

$-401875 (-40.19%)

149

Hold Since 03-Jan-2019

$652500

$652484.31 (4161252.00%)

$543750

7 years 7 months 26 days ago
(25-Feb-2019)

2/2 (100%)

$-347500 (-34.75%)

177

Show more analysts

Please expand the browser size to see the chart

What is RSLS (ReShape Lifesciences) average time for price targets to be met?

On average it took 69 days for the stock forecasts to be reached, with an average price target met ratio of 50%.

Which analyst most recently updated their price target on RSLS (ReShape Lifesciences)?

Anthony Vendetti

Which analyst has the current lower performing score on RSLS (ReShape Lifesciences) with a proven track record?

DAVID SOLOMON

Which analyst has the most public recommendations on RSLS (ReShape Lifesciences)?

Anthony Vendetti works at MAXIM GROUP and has 2 price targets and 3 ratings on RSLS

Which analyst is the currently most bullish on RSLS (ReShape Lifesciences)?

Rick Wise with the highest potential upside of $2609983.75

Which analyst is the currently most reserved on RSLS (ReShape Lifesciences)?

Anthony Vendetti with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?